Banner for leaf pages 2

Romidepsin

Also known as Istodax

Romidepsin (INN, trade name Istodax), codenamed FK228 and FR901228, is an anticancer agent undergoing clinical trials as a treatment for cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma, and a variety of other cancers. Romidepsin is a natural product obtained from the bacteria Chromobacterium violaceum, and works by blocking enzymes known as histone deacetylases and inducing apoptosis. It is sometimes referred to as depsipeptide, after the class of molecules to which it belongs.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed romidepsin to treat rabies, blastomycosis, west nile virus, and pick disease.

Ajax-loader Loading...